Abiopharma

Clinical trial NCT03835819: completion date: 2027-05-01 → 2027-02-01.

Clinical trial NCT05571969 updates: 1. status: SUSPENDED → TERMINATED 2. start date: 2023-02-20 → 2023-03-08 3. completion date: 2025-12-01 → 2024-10-07 4. primary completion date: 2024-10-01 → 2024-02-19 5. enrollment: 40 → 14 participants 6. enrollment type: ESTIMATED → ACTUAL 7. allocation: NA → NON_RANDOMIZED 8. intervention model: SINGLE_GROUP → …

Clinical trial NCT07413744: start date: 2026-05-01 → 2026-06-01.

Clinical trial NCT03651206: completion date: 2027-06-01 → 2029-03-01.

Clinical trial NCT00486980 updates: 1. enrollment: not set → 0 participants 2. enrollment type: not set → ACTUAL

Clinical trial NCT07521475 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-20 → 2026-04-30

Clinical trial NCT05412290 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 15 → 9 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07095127 updates: 1. completion date: 2026-12-31 → 2027-12-31 2. primary completion date: 2026-06-30 → 2027-06-30 3. enrollment: 10 → 30 participants

Clinical trial NCT06924320 updates: 1. start date: 2025-03-03 → 2025-03-06 2. completion date: 2027-03-15 → 2026-09-15 3. primary completion date: 2027-01-25 → 2026-09-15 4. enrollment: 132 → 381 participants 5. intervention model: PARALLEL → SEQUENTIAL

Clinical trial NCT00506870 updates: 1. primary purpose: not set → OTHER 2. collaborators added: Roche Diagnostics GmbH 3. collaborators removed: Hoffmann-La Roche